Hiroyoshi Doihara
   Department   Kawasaki Medical School  Kawasaki Medical School, Department of General Surgery,
   Position   Professor with Special Assignment
Article types 原著
Language English
Peer review Peer reviewed
Title Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study.
Journal Formal name:Breast cancer research and treatment
Abbreviation:Breast Cancer Res Treat
ISSN code:15737217/01676806
Domestic / ForeginForegin
Volume, Issue, Page 176(3),pp.631-635
Author and coauthor Ohno Shinji, Mukai Hirofumi, Narui Kazutaka, Hozumi Yasuo, Miyoshi Yasuo, Yoshino Hiroshi, Doihara Hiroyoshi, Suto Akihiko, Tamura Motoshi, Morimoto Takashi, Zaha Hisamitsu, Chishima Takashi, Nishimura Reiki, Ishikawa Takashi, Uemura Yukari, Ohashi Yasuo
Publication date 2019/08
Summary PURPOSE:While some studies show improved outcomes in clinical trial participants as compared to non-participants, existence of such a trial effect has not been proved precisely.METHODS:This was a prospective cohort study to compare the prognoses for participants in the randomized controlled trial (SELECT BC) and non-participants. SELECT BC compared S-1 and taxane as first-line treatment for metastatic breast cancer. Non-participants were all patients who met the eligibility criteria of SELECT BC and who had been requested to participate in that trial by attending doctors and declined. The study aimed to compare the prognoses between participants and non-participants. The primary endpoint was median overall survival.RESULTS:The median OS in participants was significantly superior to that in non-participants with a statistically significant difference (36.8 months vs. 25.2 months. HR 1.48, p = 0.022). A similar result was obtained when only patients who received the same chemotherapy (S-1 or taxane) used in SELECT BC after declining participation were assumed as non-participants (36.8 months vs. 22.0 months. HR 2.03, p = 0.006).CONCLUSIONS:This study may suggest the existence of a trial effect, in which, for a given treatment, participation in a clinical trial is associated with a better outcome.
DOI 10.1007/s10549-019-05276-y
PMID 31115845